Bioactivity:

Risdiplam (RG7916) is orally administered. Risdiplam is a centrally and peripherally distributed SMN2 pre-mRNA splicing modifier which increases survival motor neuron (SMN) protein levels[1].

CAS nr:

1825352-65-5

Purity:

98%

Molecular Weight:

401,46

SMILES:

O=C(C=C(C(C=C1C)=NN2C1=NC(C)=C2)N=C3C=C4)N3C=C4N(CCN5)CC65CC6

Formula:

C22H23N7O

Pathway:

DNA Damage/DNA Repair,Cell Cycle/Checkpoint

Target:

DNA/RNA Synthesis,DNA/RNA Synthesis